Richard Wenstrup, M.D.
About Richard Wenstrup, M.D.
Richard Wenstrup, M.D. serves as the Chief Medical Officer at Epic Sciences since 2019. He co-founded Assurex Health and has held prominent roles at Myriad Genetics and Oxford Immunotec, contributing significantly to medical research and product development.
Work at Epic Sciences
Richard Wenstrup, M.D. has served as the Chief Medical Officer at Epic Sciences since 2019. In this role, he contributes to the company's mission of advancing precision medicine through innovative diagnostic solutions. His leadership focuses on integrating clinical insights with scientific advancements to enhance patient care and outcomes.
Previous Roles in Medical Leadership
Prior to his current position, Richard Wenstrup held the role of Chief Medical Officer at Oxford Immunotec from 2017 to 2019. He also served as Chief Medical Officer at Myriad Genetics from 2006 to 2017. During his tenure at Myriad Genetics, he played a crucial role in product development, regulatory affairs, and clinical operations, significantly impacting the company's revenue growth.
Education and Expertise
Richard Wenstrup earned his Doctor of Medicine (MD) degree from the University of Cincinnati College of Medicine. His academic background includes serving as a tenured professor of biomedical engineering at the University of Cincinnati and pediatrics in human genetics at Cincinnati Children's Hospital Medical Center. His expertise encompasses inherited disorders of the musculoskeletal system.
Research Contributions and Grants
Richard Wenstrup has been a principal investigator on multiple research grants from the National Institutes of Health and the FDA Orphan Products Grant Program. His research efforts have contributed to advancements in understanding and treating inherited disorders, particularly in the context of musculoskeletal health.
Founding Roles and Innovations
Richard Wenstrup co-founded Assurex Health, Inc., which is now a subsidiary of Myriad Genetics, Inc. He also served as the founding director of the Molecular Diagnostics Laboratory at Cincinnati Children's Hospital. His involvement in these initiatives highlights his commitment to advancing medical diagnostics and personalized medicine.